Identifying survival predictors for breast cancer patients with and without HIV in South Africa
Official title: Novel predictors of survival among breast cancer patients with/without HIV in South Africa
Funded at Wits Health Consortium (Pty), LTD · NIH-10851806 · Data updated 2026-11-12
This study is looking at how having HIV and taking HIV medicine might impact breast cancer treatment and recovery for women in South Africa, with the goal of finding better ways to help them survive and thrive.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wits Health Consortium (Pty), LTD NIH-funded |
| Lab location | 1 site (Parktown, South Africa) |
| Project start | June 1, 2020 |
| Project end | May 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $345,761 |
| NIH project number | 5R01CA250012-05 |
| Project ID | NIH-10851806 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include women diagnosed with breast cancer in South Africa, particularly those who are HIV positive.
✕Less likely to help
Patients who do not have breast cancer or are not located in South Africa may not benefit from this research.
What this research studies
This research investigates how HIV infection and antiretroviral therapy (ART) affect breast cancer treatment and outcomes among women in South Africa. By analyzing data from over 3,000 breast cancer patients, including those who are HIV positive, the study aims to identify factors that influence survival rates. The research builds on previous findings and seeks to improve understanding of the interplay between HIV and breast cancer, ultimately guiding better treatment strategies. Patients will be monitored for their clinical characteristics and treatment responses over time.
Why it matters
Potential benefit: If successful, this research could lead to improved survival rates and treatment protocols for breast cancer patients living with HIV.
How similar studies have gone: Previous studies have shown promising results in understanding the relationship between HIV and breast cancer, indicating that this research builds on established findings.
Where this research is happening
-
Wits Health Consortium (Pty), LTD
Parktown, South Africa Active
Researchers
- Principal investigator: Joffe, Maureen — Wits Health Consortium (Pty), LTD
- Study coordinator: Joffe, Maureen
Related research
Other NIH-funded projects on the same topics.
-
Improving Breast Cancer Guideline Adherence in Nigeria
Aimed at helping doctors in Nigeria follow international guideline-based breast cancer care to improve outcomes for women with breast cancer.
-
Genomic study to understand how genetics and epigenetics shape triple-negative breast cancer in African ancestry
This study looks at how inherited genes and gene activity affect triple-negative breast cancer in people of African ancestry to better understand why outcomes can be worse.
-
Translational breast cancer research to improve treatment options
A comprehensive program at Baylor College of Medicine is focusing on breast cancer; researchers will advance targeted therapies and biomarkers to help patients with aggressive or hard-to-treat forms.
-
Cancer Pain Management for Asian American Breast Cancer Survivors with Depressive Symptoms
A technology-based program helps Asian American breast cancer survivors with depressive symptoms manage chronic pain more effectively from home using a web app and mobile tools.
-
Co-Targeting IL-6 and CDK4/6 to Prevent TNBC in Women Veterans
A study aims to block two cancer-promoting pathways (IL-6 and CDK4/6) to prevent or reduce progression of triple-negative breast cancer in women veterans.
-
Gut bacteria and metabolites linked to breast density and cancer risk
A small, patient-friendly study will explore whether gut bacteria and their byproducts are connected to high breast density, which can raise cancer risk and make screening less accurate.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.